Academic weight management center, patients who received structured dietary counseling before starting therapy had a 31% lower rate of GI-related discontinuation at six months compared to those who received standard pharmacist instructions alone ([11])
[11] Semaglutide (Wegovy) a GLP-1 receptor agonist approved by the MHRA for chronic weight management
Harvey and Consumer Affairs Director, Kimberly Ricketts, announced that Goen Technologies Corp
The other difference worth noting is mechanism
But these results might not apply to everyone The cohort was 90% male with an average age of 65, so findings may not extend to women, younger people, or those without type 2 diabetes
The decision must be individualised based on weight loss trajectory, nutritional status, and overall health outcomes